433 related articles for article (PubMed ID: 31791394)
1. The timeline of epigenetic drug discovery: from reality to dreams.
Ganesan A; Arimondo PB; Rots MG; Jeronimo C; Berdasco M
Clin Epigenetics; 2019 Dec; 11(1):174. PubMed ID: 31791394
[TBL] [Abstract][Full Text] [Related]
2. Drug discovery for epigenetics targets.
Holdgate GA; Bardelle C; Lanne A; Read J; O'Donovan DH; Smith JM; Selmi N; Sheppard R
Drug Discov Today; 2022 Apr; 27(4):1088-1098. PubMed ID: 34728375
[TBL] [Abstract][Full Text] [Related]
3. PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance.
Giardina SF; Valdambrini E; Warren JD; Barany F
Curr Cancer Drug Targets; 2021; 21(4):306-325. PubMed ID: 33535953
[TBL] [Abstract][Full Text] [Related]
4. Exploring the epigenetic drug discovery landscape.
Prachayasittikul V; Prathipati P; Pratiwi R; Phanus-Umporn C; Malik AA; Schaduangrat N; Seenprachawong K; Wongchitrat P; Supokawej A; Prachayasittikul V; Wikberg JE; Nantasenamat C
Expert Opin Drug Discov; 2017 Apr; 12(4):345-362. PubMed ID: 28276705
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
6. Design of small molecule epigenetic modulators.
Pachaiyappan B; Woster PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):21-32. PubMed ID: 24300735
[TBL] [Abstract][Full Text] [Related]
7. Epigenome engineering in cancer: fairytale or a realistic path to the clinic?
Falahi F; Sgro A; Blancafort P
Front Oncol; 2015; 5():22. PubMed ID: 25705610
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Epigenetics and Anticancer Drug Discovery.
Jin P; Chen X
Anticancer Agents Med Chem; 2016; 16(6):699-712. PubMed ID: 26567620
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic opportunities and challenges in cancer.
Best JD; Carey N
Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and oncology.
Mummaneni P; Shord SS
Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Complexity of Epigenetic Target Space.
Pande V
J Med Chem; 2016 Feb; 59(4):1299-307. PubMed ID: 26796965
[TBL] [Abstract][Full Text] [Related]
13. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
14. HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs.
Shah SG; Mandloi T; Kunte P; Natu A; Rashid M; Reddy D; Gadewal N; Gupta S
Epigenetics Chromatin; 2020 Aug; 13(1):31. PubMed ID: 32746900
[TBL] [Abstract][Full Text] [Related]
15. Towards a more precise therapy in cancer: Exploring epigenetic complexity.
CossÃo FP; Esteller M; Berdasco M
Curr Opin Chem Biol; 2020 Aug; 57():41-49. PubMed ID: 32480315
[TBL] [Abstract][Full Text] [Related]
16. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
Cacabelos R
Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery.
Ganesan A; Nolan L; Crabb SJ; Packham G
Curr Cancer Drug Targets; 2009 Dec; 9(8):963-81. PubMed ID: 20025605
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening in small molecule discovery for epigenetic targets.
Li GB; Yang LL; Yuan Y; Zou J; Cao Y; Yang SY; Xiang R; Xiang M
Methods; 2015 Jan; 71():158-66. PubMed ID: 25462557
[TBL] [Abstract][Full Text] [Related]
19. Current trends in epigenetic drug discovery.
Stolfa DA; Einsle O; Sippl W; Jung M
Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
[TBL] [Abstract][Full Text] [Related]
20. Role of epigenome in tumorigenesis and drug resistance.
Hu Q; Baeg GH
Food Chem Toxicol; 2017 Nov; 109(Pt 1):663-668. PubMed ID: 28709969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
